Genmab at SCOPE 2027

Mar 1–4, 2027 Orlando, FL ~5k attendees Website

Genmab brings 2 presentations to SCOPE 2027 in Orlando. Its sessions cover AI in drug safety work and what it costs to deploy AI across clinical development. A concrete topic is AI-assisted literature surveillance that retrieves and then ranks relevant publications.

OrganizationSCOPE 2027 Attendance
Genmab
Copenhagen, Denmark
genmab.com
Biotech
Danish antibody company with marketed cancer medicines, including Epkinly and Tivdak, and royalties on Darzalex.
Talk
Tue Mar 2
12:20pm–12:45pm
AI-Assisted Literature Surveillance: A Two-Stage Framework for Retrieval and Ranking
Safety & Pharmacovigilance
Panel
Tue Mar 2
4:45pm–5:10pm
The Financial Cost of AI in Clinical Development: Strategies for Scalable and Cost-Effective Deployment
AI in Clinical Research · with Endpoint Clinical, Thermo Fisher Scientific, Johnson & Johnson +2 more

Explore the full SCOPE 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full SCOPE 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Genmab

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by SCOPE Summit or its organizers. Submit a correction